Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 2 open reading frame 74 (C2orf74) encodes an uncharacterized human protein found on chromosome 2p15, with two major isoforms generated by alternative splicing[1][5][8]. Isoform 1 is a predicted single-pass transmembrane protein with a domain of unknown function (DUF), predominately helical in structure, and localized to intracellular membranes such as the nuclear membrane, mitochondria, and endoplasmic reticulum[1]. The gene’s expression is generally low, with possible enrichment in brain and colon tissues[1][4]. C2orf74 is conserved in placental mammals and marsupials and is annotated as having protein binding molecular function, suggesting it may be part of molecular complexes rather than an independent effector enzyme or receptor[10]. Disease associations include susceptibility to Crohn’s disease, ankylosing spondylitis, and altered expression in colorectal tumors, most likely through indirect or as-yet-uncharacterized mechanisms[1][5]. No known drugs, direct biomarker utility, or safety concerns are documented, highlighting its poorly defined functional status and absence as a recognized therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 2 open reading frame 74 (C2orf74).